Phase II chemoprevention trial - anastrozole in the DCIS [ductal carcinoma in situ] and early invasive breast cancer in postmenopausal women

Trial Profile

Phase II chemoprevention trial - anastrozole in the DCIS [ductal carcinoma in situ] and early invasive breast cancer in postmenopausal women

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 30 Jan 2014

At a glance

  • Drugs Anastrozole (Primary)
  • Indications Early breast cancer
  • Focus Biomarker; Therapeutic Use
  • Most Recent Events

    • 30 Jan 2014 Planned End Date changed from 1 Aug 2012 to 1 Dec 2018 as reported by ClinicalTrials.gov record.
    • 30 Jan 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
    • 09 Mar 2010 Planned end date changed from 1 Dec 2009 to 1 Aug 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top